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Genotoxic stress caused by carcinogens like Cigarette smoke 
activate both the MAPK pathway and the S phase checkpoint in 
Schizosaccharomyces pombe. But the cross talk between these two 
pathways has not been investigated in great detail in fission yeast. 
This study deals with the molecular mechanism of co-ordina-
tion between the two regulatory pathways. We show that both 
the pathways have a common effector molecule, namely Cdc25, 
the cell cycle regulatory phosphatase. We demonstrate that the 
MAPK Sty1 interacts with Cdc25 and prevents mitotic entry in 
S. pombe cells exposed to CSE. To our knowledge, this is the first 
demonstration of interaction between Sty1 and Cdc25 in S. pombe. 
The functional significance of this interaction lies in effecting 
Cdc25 turnover after CSE exposure in S. pombe. We show that 
Cdc25 turnover after CSE treatment is dependent on the presence 
of Rad3 activity and Sty1-Cdc25 interaction. Our study suggests 
that the Cigarette Smoke Extract (CSE) induced stress is counter-
acted by the simultaneous activation of a mitotic checkpoint in 
addition to the previously described S phase checkpoint. We also 
show that Sty1 activity is not essential for activation of the S phase 
checkpoint.
Introduction
The DNA damage detection, repair and checkpoint activation 
pathways are evolutionarily conserved from yeast to human to an 
appreciable extent, as are the stress responsive MAPK pathways. 
Specifically the major players in these pathways in mammals have 
their well described homologues in S. pombe. This makes S. pombe a 
very good model system for studying the cellular responses to various 
stress conditions including DNA damage, as the extrapolation of the 
results to mammalian systems is sufficiently relevant. We have already 
established S. pombe as a model system for studying the cellular 
responses to Cigarette Smoke Extract (CSE) (Chaudhuri et al.1).
Cigarette Smoke (CS) has been classified as a group A carcinogen 
and smoking is known to be associated with a variety of diseases like 
emphysema, chronic obstructive pulmonary disease, atherosclerosis, 
cardiovascular diseases, neurodegenerative diseases and different 
types of cancer, most importantly lung cancer (Sherman CB2). 
Thus elucidation of the intricate molecular interactions that help 
the cell to survive after being exposed to CS are necessary to under-
stand the mechanism of CS induced disease progression. Cigarette 
smoke contains 4,700 chemical compounds including sixty known 
carcinogens and many oxidants and free radicals that are capable of 
initiating or promoting oxidative damage. Apart from the oxidants 
present in cigarette smoke, the reactive oxygen species generated by 
the activated phagocytes following smoking, may also be responsible 
for the observed oxidative damage (Chow CK3). The high level of 
oxidative potency of cigarette smoke accounts for its capacity to 
oxidize proteins (reviewed in refs. 4–6;), lipids (reviewed in refs. 5 
and 7), and DNA (reviewed in refs. 8–10). It has been demonstrated 
to induce chromosomal aberrations (Hirao et al.11), sister chromatid 
exchange (Lambert et al.12) and DNA damage including single 
strand break (reviewed in refs. 13 and 14). Cumulatively, these 
effects can cause extensive damage to tissues and organs (Panda et 
al.15) and potentially contribute to different diseases associated with 
smoking.
Our previous studies have shown that treatment with sub-lethal 
doses of CSE leads to S phase checkpoint activation as well as the 
MAPK Sty1 activation in S. pombe. The S phase checkpoint activa-
tion is dependent on Rad3, which is homologous to the mammalian 
ATM/ATR family of protein kinases. The activation of Rad3 initiates 
the activation/inhibition of a series of downstream effector molecules 
including Cds1, which ultimately leads to cell cycle arrest and 
damage repair. Cell cycle progression in S. pombe requires the activity 
of the cyclin dependent kinase Cdc2, which is very tightly regulated. 
The tyrosine kinases Wee1 and Mik1 can phosphorylate Cdc2 on 
Tyr15 thereby inhibiting its activity (reviewed in refs. 16–18). Cdc25 
phosphatase can remove this inhibitory phosphorylation and activate 
Cdc2 (reviewed in refs. 19–21). In turn Cdc25 activity is regulated by 
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a negative regulatory phosphorylation by the kinases Chk1 and Cds1 
under the conditions of incomplete replication or DNA damage 
(Furnari et al.22). The MAPK Sty1 on the other hand, responds to 
a wide spectrum of stress stimuli. It is the homolog of mammalian 
p38 and S. cerevisiae Hog1. Interestingly many extracellular stimuli 
like UV or gamma-radiation, DNA damaging compounds etc. have 
been shown to effect cell cycle checkpoint activation in a p38 depen-
dent manner in mammalian cells (reviewed in refs. 23–29). Sty1 also 
has been shown to link cell cycle progression with environmental 
stress in S. pombe (reviewed in refs. 30–32), but the exact molecular 
mechanism is not known, except when the inhibition of Cdc25 
occurs through the activity of the Srk1 kinase which is dependent on 
Sty1 for its activation (Lopez-Aviles et al.33). Srk1 however cannot 
regulate Cdc25 when cells are exposed to genotoxic stress.
In this report we provide evidences, which suggest that both the 
Rad3-Cds1 dependent S phase checkpoint pathway and the Sty1 
MAPK pathway independently regulate the activity of Cdc25 to 
synergize the cellular responses towards CSE treatment, thus ensuring 
full protection. We show that Sty1 can physically associate with Cdc25 
in vivo in CSE treated S. pombe cells and inhibit mitotic entry of CSE 
exposed fission yeast cells, and that this association is required for 
degradation of Cdc25 after CSE treatment. Importantly, association 
of Cdc25 and Sty1 was also found in fission yeast cells treated with 
HydroxyUrea also indicating a more general role for this association. 
The investigation of possible cross talks between MAPK activity and 
cell cycle regulation also shows that neither Sty1 nor its downstream 
effector Atf1 can inhibit Cds1 activation in CSE treated cells.
Results
Δrad3Δsty1 cells are highly sensitive to CSE. The first indica-
tions for a role of Sty1 in cell cycle modulation after CSE treatment 
came from the observations on the sensitivities of the respective 
mutants to CSE. Wild type, Δsty1, Δrad3 and Δrad3Δsty1 cells were 
exposed to 40 ul CSE and cell death was determined by the extent 
of PI uptake (Fig. 1A). The Δrad3Δsty1 cells exhibited extreme sensi-
tivity to CSE, much higher than the additive sensitivity of the Δrad3 
and Δsty1 cells. Chronic exposure to CSE, rendered the Δrad3Δsty1 
mutant completely non—viable (Fig. 1B). ROS generation profiles 
of the CSE treated mutants showed similar trends (Fig. 1C).
S phase checkpoint is intact in Δsty1 cells. The cell sensitivity 
data strongly indicated the existence of a synergistic interaction 
between the Rad3 and Sty1 mediated pathways. So we next investi-
gated whether Sty1 could affect the Rad3 dependent S phase arrest 
in S. pombe cells exposed to CSE. Wild type and Δsty1 cells treated 
with 40 ul CSE were fixed at definite time intervals, processed (as 
described in Materials and Methods) and the cell cycle progression 
was monitored. Intriguingly we observed that both the wild type 
and Δsty1 mutants showed activation of the S phase checkpoint, 
wherein CSE treatment causes a fraction of the cells to accumulate 
with a DNA content intermediate between 1N and 2N (Fig. 2A). 
The biochemical hallmark of S phase checkpoint activation in CSE 
treated S. pombe cells is the activation of the checkpoint kinase Cds1 
(downstream of Rad3) (Chaudhuri et al.1). We found that increase in 
Cds1 activity after CSE treatment was not affected by the deletion of 
either Sty1 or its downstream effector Atf1 (data not shown). Hence 
loss of sty1 activity does not compromise the CSE induced S phase 
delay in S. pombe. So any possible synergistic interaction between the 
two pathways is not affecting the S phase checkpoint activation after 
CSE treatment.
Sty1 regulates mitotic progression in CSE treated cells. Now that 
we knew that Sty1 was not affecting the S phase delay, we went on to 
investigate what else could be the overlapping role of Sty1 with the 
cell cycle regulatory pathway in S. pombe. To this end we searched 
for any enhanced cell division defects in CSE treated Δsty1 cells. It 
was observed that the CSE treated Δsty1 cells exhibit multiple and 
abnormal septation (Fig. 3A, part iii), a phenotype that is highly 
Figure 1. Potential synergism between the Rad3 and Sty1 mediated signal-
ing. (A) Wild type, Δrad3,Δsty1,Δrad3Δsty1 S. pombe cells were treated 
with CSE and the sensitivity of these different cell populations to CSE was 
Flow Cytometrically determined by Propidium Iodide (PI) uptake at 2 and 4 
hrs after CSE treatment. The data was normalized to the PI uptake values 
before treatment in each of the cell populations. (B) Viability of S. pombe 
wild type, Δrad3, Δsty1 and Δrad3Δsty1 cells in the presence or absence 
of a chronic exposure to CSE was determined by spotting serial 10-fold 
dilutions of the different cells types in YES-Agar plates containing CSE and 
compared with the viability of cells spotted similarly on YES-Agar plates not 
containing CSE. The plates were incubated at 30°C for three days before 
being photographed. (C) S. pombe cells were treated with CSE for the indi-
cated time intervals, washed in YES and then incubated for 30 mins in the 
dark with the dye H2DCF-DA. Intracellular ROS levels in S. pombe wild type, 
Δrad3, Δsty1, Δrad3Δsty1 cells before and after CSE treatment was then 
measured flow cytometrically through H2DCF fluorescence.
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However CSE treated Δrad3 cells also did not undergo abnormal 
mitosis. Hence the mechanism for repair or prevention of aberrant 
mitosis does not appear to be dependent on the activation of the 
S phase checkpoint following CSE treatment. However this repair 
appeared to be severely impaired in both Δsty1 and Δsty1Δrad3 cells. 
Hence Sty1 must be having a role in ensuring that mitotic aberrations 
did not accumulate in CSE treated S. pombe cells. To investigate what 
this role was, asynchronously growing wild type and Δsty1 cells were 
treated with CSE and the growth and mitotic progression of both cell 
populations was monitored. We observed that there is a significant 
growth arrest in both wild type and Δsty1 cells after CSE treatment 
(Fig. 3B). Mitotic progression was determined and expressed as the 
Mitotic index, i.e., the percentage of single, non-septate, binucleate 
cells in the population. We found that CSE treatment causes an 
appreciable decrease in mitotic index in the wild type population 
within 30 mins of exposure (Fig. 3C, part i), whereas a comparable 
decrease in the mitotic index of CSE treated Δsty1 wasn’t seen before 
at least 1.5 hrs post CSE exposure (Fig. 3C, part ii), although in case 
of both the cell types the cells number ceases to increase after CSE 
treatment (Fig. 3B). These results clearly 
show that Sty1 is required for slowing 
down mitotic progression in CSE treated 
cells and in absence of this Sty1 mediated 
delay, the cells undergo aberrant mitosis, 
thus leading to mitotic catastrophe. So 
S. pombe cells respond to CSE treatment 
by activating two defense strategies, namely 
the slowed mitotic progression and the 
slowing of S phase. Absence of both these 
pathways in the Δrad3Δsty1 renders them 
extremely sensitive to CSE.
Sty1 associates with Cdc25 in vivo. The 
next logical step was obviously to probe into 
the molecular mechanism by which Sty1 
activates a mitotic checkpoint. Now, if Sty1 
has to bring about a cell cycle delay, it has 
to directly or indirectly affect the regulation 
of any of the important cell cycle regulatory 
molecules. One prime suspect was the cell 
cycle regulatory phosphatase Cdc25. The 
reasons behind implicating Cdc25 was that 
Sty1 being a Ser/Thr Kinase had the poten-
tial to inhibit Cdc25, as the latter is known 
to be inactivated after Ser phosphorylation. 
Chances were that if Sty1 could function 
in Cdc25 inhibition then we might find 
Cdc25 associated with Sty1 in CSE treated 
S. pombe cells. So, total Sty1 was immuno-
precipitated from CSE treated wild type 
KS1376 S. pombe cells (which have a HA-
tagged genomic copy of Sty1) at different 
times after treatment and transferred onto PVDF membrane. 
Imunoblotting with anti Cdc25 antibodies revealed the presence of 
associated Cdc25 with the immunoprecipitated Sty1 (Fig. 4A), thus 
confirming our suspicions. The extent of this association peaked at 
10 mins after treatment. Sty1 activation after CSE treatment has 
been shown to be maximal around this time also (Chaudhuri et al.1). 
Figure 2. Activation of S phase checkpoint in Δsty1 cells. Wild type and 
Δsty1 S. pombe cells were treated with CSE, cells were collected at definite 
intervals after CSE treatment, fixed, and then the cell cycle progression in 
these cells was flow cytometrically monitored by staining with PI and deter-
mining the DNA content of these cells.
Figure 3. For figure legend, see page 4.
aggravated in the Δrad3Δsty1 mutants (Fig. 3A, part iv). Such abnor-
malities are not observed in either wild type (Fig. 3A, part i) or the 
Δrad3 (Fig. 3A, part ii) cells. Absence of abnormal septation indicated 
that CSE treated wild type cells have a mechanism to ensure that the 
cells do not accumulate with mitotic abnormalities. CSE induced 
S phase checkpoint is absent in Δrad3 cells (Chaudhuri et al.1). 
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Figure 3. Sty1 dependent mitotic delay in 
S. pombe. (A) Wild type and Δsty1, Δrad3 and 
Δrad3Δsty1 cells were treated with CSE and 
then stained with calcoflour and the observed 
through a fluorescence microscope at a magni-
fication of 63X. Abnormal septation in Δsty1(iii) 
and Δrad3 Δsty1(iv) cells was seen after CSE 
treatment for 2 hrs. No such defects are seen 
in wt(i) and Δrad3(ii) cells. (B) Wild type and 
Δsty1cells were grown in the presence and 
absence of CSE and the cell number in these 
populations was determined at regular time 
intervals to monitor the growth of these cells. 
(C) Wild type and Δsty1cells were grown in the 
presence and absence of CSE and the Mitotic 
index of these cells was determined by calculat-
ing the % of single binucleate non-septate cells. 
In all the figures (a) represents the untreated 
cells and the rest represent cells treated with 
CSE for 2 hrs.
Thus CSE treatment activates Sty1, which 
can then associate with Cdc25 and inhibit 
its activity, thus blocking the cells’ entry 
into mitosis. Genetic studies in S. pombe 
have earlier pointed to a link between Sty1 
and Cdc25 activity but this study, to our 
knowledge, is the first report of direct inter-
action between Sty1 and Cdc25 in S. pombe 
in vivo. Further investigation is however 
needed to confirm whether this interaction 
leads to any direct or indirect modification 
of Cdc25. Reverse immunoprecipitation 
experiments where Cdc25 was immuno-
precipitated from CSE treated wild type 
cells and then immunoblotting was done 
using anti p38 antibodies confirmed this 
interaction (data not shown). So we knew 
now how Sty1 was bringing about the 
delayed mitotic progression. It was neces-
sary to find out whether this function of 
Sty1 was in any ways modulated by Rad3. 
While investigating such a possibility we 
actually found that Cdc25 immunopre-
cipitated from Δrad3 cells treated with CSE 
was still found to be associated with Sty1 
but unlike the case for the wild type cells, 
there was a significant continuation of this 
association upto 30 mins after treatment 
(Fig. 4B). Hence although Rad3 activity is 
not essential for initiating the interaction 
between Sty1 and Cdc25, but temporal regulation of this interaction 
definitely depends on Rad3 activity. Wild type S. pombe cells were 
then subjected to stress condition other than CSE and it was found 
that the associtation of Sty1 with Cdc25 is not CSE specific. The Sty1 
-Cdc25 interaction was present in HU treated cells and to a much 
lesser extent in H2O2 treated cells (Fig. 4C).
CSE induced Cdc25 degradation depends on Sty1-Cdc25 inter-
action. The demonstration of this novel interaction between Sty1 and 
Cdc25 made it important to look for its functional significance. Wild 
type, Δsty1 and Δrad3 cells were separately treated with CSE and 
cells were harvested at 0, 10, 20, 30 and 60 minutes after treatment. 
Denatured extracts were prepared and equal amounts of total protein 
from these extracts were resolved on 10% SDS-PAGE. Subsequently 
Cdc25 levels were monitored by immunoblotting. It was observed 
that when wild type S. pombe cells are treated with CSE, there is a 
rapid decrease in the total Cdc25 levels (Fig. 5A). Hence treatment 
with CSE leads to degradation of Cdc25 resulting in the observed 
cell cycle arrest. Interestingly under similar conditions there is no 
Cdc25 degradation at all in Δsty1 cells (Fig. 5B). Even in Δrad3 cells 
there is only a slight decrease in total Cdc25 levels, at 60 mins after 
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CSE treatment (Fig. 5C). Expectedly, in Δrad3Δsty1 cells the Cdc25 
levels remain fairly constant (Fig. 5D).
Hence the CSE mediated degradation of Cdc25 was impaired in the 
absence of either Sty1 or Rad3 activity. Rad3 mediated Cdc25 degra-
dation in S. pombe during S phase arrest is well documented. Here we 
show that both Rad3 dependent inhibition of Cdc25 and the interac-
tion between Sty1 and Cdc25 are equally important for effecting the 
Cdc25 degradation and cell cycle arrest resulting from CSE treatment.
We investigated whether this Cdc25 degradation is reflected in 
Cdc2 activity. We found that the levels of inhibitory Tyr 15 phos-
phorylation on Cdc2 show an oscillating pattern in CSE treated wild 
type cells (Fig. 6A), while it remains constant in Δsty1 (Fig. 6B) cells 
under similar conditions. This shows that there might be a more 
complex role of Sty1 in the regulation of Cdc2 activity, probably 
mediated through Wee1 or Mik1 kinases. This possibility however 
needs further investigation.
Discussion
In this report we demonstrate a novel pathway of modulation of 
cell cycle regulatory molecules in S. pombe, namely, the activation of 
a mitotic checkpoint by the MAPK Sty1.
Interstingly many extracellular stimuli like UV or gamma-radia-
tion, DNA damaging compounds etc have been shown to activate 
cell cycle checkpoints in a p38 dependent manner in mamma-
lian cells. p38 has been demonstrated to bind and phosphorylate 
Cdc25B, Cdc25C and Cdc25A (Bulavin et al.,24 Lemaire et al.,25 
Kittipatarin et al.36). ERK has also been shown to phosphorylate 
Cdc25C (Eymin et al.37). Our data shows that a similar mechanism 
is present in S. pombe also. We show that MAPK activity is related to 
Cdc25 turnover in S. pombe. Although a role for Sty1 has long been 
implicated in Cell cycle regulation in S. pombe, this is the first study 
illustrating the molecular mechanism behind this regulation.
This is the first report demonstrating the direct physical associa-
tion of Sty1 and Cdc25. We show that CSE treated S. pombe cells 
face two different checkpoints in order to counteract the damage 
caused by CSE. We had previously shown that CSE treated S. pombe 
cells are arrested in S phase in a Rad3—Cds1 dependent manner 
(Chauduri et al.1). We now add that CSE treated S. pombe cells also 
exhibit a delay in mitotic progression. The activation of this mitotic 
checkpoint requires the activity of the MAPK Sty1. Sty1 activated 
Figure 4. Sty1 inhibits Cdc25 in CSE treated S. pombe cells. (A) Sty1 was 
immunoprecipitated from wild type cells treated with CSE at 0, 10, 20, 
30 and 60 mins after treatement, resolved on 10% SDS-PAGE and then 
immunoblotted with Anti Cdc25 antibodies. Physical Association of Sty1 
with Cdc25 in vivo was observed in wild type S. pombe cells treated with 
CSE. (B) Δrad3 cells were also treated with CSE and Cdc25 was immuno-
precipitated at similar time intervals after treatment. The immunoprecipitated 
complexes were resolved on 10% SDS-PAGE and then immunoblotted with 
anti p38 antibodies to reveal associated Sty1 (C) Wild type S. pombe cells 
were treated with CSE, 20 mM Hydroxyurea(HU), or 5 mM Hydrogen 
Peroxide(H2O2) and the extent of association between Cdc25 and Sty1 was 
determined similarly as in (A).
Figure 5. Sty1 activity regulates Cdc25 turnover after CSE treatment. (A) 
Wild type (B) Δsty1(C) Δrad3 and (D) Δrad3Δsty1 cells were treated with 
CSE. Cells were harvested at 0, 10, 20, 30 and 60 mins after treatment, 
denatured extracts were prepared and Cdc25 levels were determined by 
immunoblotting with anti Cdc25 antibodies.
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in response to CSE slows down mitotic progression in CSE treated 
S. pombe cells and thus prevents a mitotic catastrophe. Based on the 
above findings we propose a modified model for cellular response 
to CSE in S. pombe (Fig. 7). We show that Sty1 is necessary for the 
CSE induced delay in mitotic progression in S. pombe cells. This is 
achieved through the in vivo association of Sty1 with the cell cycle 
regulatory phosphatase Cdc25 and the resulting degradation of 
Cdc25. This interaction between Sty1 and Cdc25 is not specific to 
CSE but is also present in S. pombe cells treated with Hydroxyurea. 
Thus this mechanism represents a general mode of cell cycle regula-
tion in S. pombe. Both CSE and Hydroxyurea are potent genotoxins. 
They cause extensive DNA damage which also leads to generation 
of free radicals inside the cells. Either the DNA damage or the 
resulting generation of free radicals or both might be responsible for 
the observed Sty1-Cdc25 interaction. We show that Rad3 activity is 
important for temporal regulation of the interaction between Sty1 
and Cdc25. Our observations suggest that the cell cycle regulatory 
and the MAPK signaling pathways converge at the common effector 
molecule, namely the Cdc25 phosphatase. Absence of either of these 
two pathways increases the cells’ sensitivity to CSE and the absence 
of both is extremely deleterious to cell survival. We also show that 
there is huge ROS accumulation in the Δsty1Δrad3 double mutant 
after CSE treatment. It is possible that failure to activate cell cycle 
checkpoints leads to accumulation of DNA damage in these cells 
after CSE treatment. This in turn would lead to generation of free 
radicals as manifested by an increase in intracellular ROS levels. This 
may also lead to the observed high sensitivity of the Δsty1Δrad3 cells 
to CSE.
It needs to be mentioned here that Sty1 mediated Cdc25 degra-
dation does not co-relate directly with the levels of inhibitory Tyr15 
phosphorylation on Cdc2 (Fig. 6). This indicates the probable pres-
ence of a more complex regulation of Cdc2 activity downstream of 
or parallel to the Sty1—Cdc25 interaction. The differential levels 
of phospho Cdc2(Tyr15) in CSE treated Δsty1 and wild type cells 
suggests that apart from regulating Cdc25 degradation, Sty1 may 
influence the activity of Cdc2 also. However this possibility needs 
further investigation.
This study also investigates whether the CSE induced S phase 
delay is in anyway dependent on MAPK activity. We clearly show 
that Sty1 does not affect the S phase checkpoint activation. ATF2 
the mammalian homologue of S. pombe Atf1, a Sty1 dependent tran-
scription factor has been earlier reported to have a role in regulating 
the activity of Chk2 (mammalian homologue of S. pombe Cds1) 
during DNA damage response (Bhoumik et al.38), but we observed 
that neither Sty1 nor Atf1 activity is essential for Cds1 activation 
during cellular response to CSE treatment (data not shown).
The association of Sty1 with Cdc25 in CSE treated S. pombe 
cells implicates a novel role of Sty1 in Cell cycle regulation upon 
genotoxic stress. The functional significance of this association is seen 
at the level of Cdc25 degradation in response to CSE. Our studies 
have clearly demonstrated that both Rad3 dependent inhibition of 
Cdc25 and the interaction between Sty1 and Cdc25 are significantly 
important for Cdc25 degradation and cell cycle arrest in response to 
CSE treatment. This interdependence of Sty1 and Rad3 in regulating 
Cdc25 turnover is the hallmark of the synergism between the two 
signaling cascades regulated by the individual proteins. These findings 
also give an extended insight into how human cells may potentially 
react to Cigarette smoke exposure. Interaction between their respec-
tive homologs in humans, p38 and Cdc25A/B/C respectively in cells 
treated with CSE has not been reported earlier, but our findings 
strongly suggest that the activation of p38 might lead to the activation 
of a similar mitotic checkpoint in human cells exposed to Cigarette 
smoke. Together these findings elucidate the importance of Sty1/p38 
in counteracting genotoxic stress and strengthen the ideas behind the 
emerging role of p38 as a tumor suppressor (Timofeev et al.39).
Materials and Methods
Fission yeast strains, media and growth conditions. S. pombe 
strains used in this study are listed in Table 1. All cells were grown 
at 30°C in the rich medium (YES), as described previously (Moreno 
et al.34).
Preparation of cigarette smoke extract (CSE) and CSE treat-
ment. Preparation of CSE and treatment was done as described 
before (Chaudhuri et al.1). Unless otherwise mentioned all treat-
ments with CSE were done at a dose of 40 ul CSE/8 x 106 cells.
Figure 6. (A) wild type and (B) Δsty1cells were treated with CSE. Cells were 
harvested at 0, 10, 20, 30 and 60 mins after treatment, denatured extracts 
were prepared and the levels of inhibitory phosphorylation on Cdc2 was 
determined by immunoblotting with anti phosphoCdc2 (Tyr15) antibodies.
Figure 7. Proposed model for Cellular responses to CSE. CSE treatment leads 
to activation of both Rad3 and Sty1.The activated Sty1 then associates with 
the cell cycle regulatory phosphatase Cdc25. This interaction is not CSE 
specific and is present in S. pombe cells treated with HU as well. Temporal 
regulation of Sty1-Cdc25 interaction is Rad3 dependent. The Sty1-Cdc25 
interaction is responsible (along with Rad3 activity) for Cdc25 turnover 
required for cell cycle arrest in S. pombe cells exposed to CSE.
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Fluorescence microscopy. Fission yeast nuclei and septum 
were stained with 4', 6'-diamidino-2- phenylindole (DAPI) and 
Calcofluor, respectively, as described previously (Moreno et al.34). 
After staining, cells were examined using Zeiss LSM 510 Meta Laser 
Scanning Confocal Microscope at 63X magnification. The mitotic 
index was determined by counting the percentage of single (non 
septate) binucleate cells. All images were taken and processed with 
the use of identical parameters. For all quantitative experiments at 
least 400 cells were examined in each sample.
Flow cytometry. For cell cycle monitoring, asynchronously growing 
fission yeast cells were treated with CSE as described above and were 
fixed in 70% ethanol at indicated time points and stored at 4°C. 
For measuring DNA content, cells were washed once with 50 mM 
sodium citrate, then resuspended in the same buffer containing 0.1 
mg/ml RNase A (Bangalore Genei) and incubated at 37°C for at least 
2 hrs. Cells were then stained with the same buffer supplemented with 
4 μg/ml Propidium Iodide and analyzed by a Becton Dickinson FACS 
Calibur. Data were analyzed by CellQuest software for Macintosh.
For cell death measurement cells treated with CSE were collected 
at the indicated time points and stained with Propidiun Iodide 
(without fixing). Only dead cells take up PI. So PI uptake can be 
used to asses cell death. % of cells having higher PI fluorescence than 
unstained cells in each case was determined. The data so obtained 
was normalized with respect to the cell death in untreated cell popu-
lations in each strain. The data represent mean of three independent 
experiments. For ROS level determination cells treated with CSE 
were collected at the indicated time points, washed in YES and 
incubated for further 30 mins with 10 uM H2DCF-DA. H2DCF-
DA is a cell permeable substance. Cellular esterases can cleave the 
ester linkage and convert it into a flourophore trapped inside the 
cell. Intracellular ROS can then oxidize H2DCF to a fluorescent 
molecule and its fluorescence is thus comparable to intracellular ROS 
levels. % of cells having higher fluorescence than the unstained cells 
was determined for each sample. The data represent mean of three 
independent experiments.
Immunoprecipitations and immunoblotting. Cells were collected 
by rapid filtration following CSE exposure at indicated time points 
and cell extracts were made under native conditions. Sty1 was 
immunoprecipitated from wild type cells using the strain KS1376, 
which carries a chromosomal copy of Spc1 having a C-terminal tag 
with two copies of the influenza virus hemagglutinin (HA) epitope 
followed by six consecutive histidine residues (reviewed in refs. 31 
and 35), using anti-HA(12CA5) antibodies (1:100, Santa Cruz). 
Cdc25 was immunoprecipitated using polyclonal Cdc25A antibodies 
(1:100, Santa Cruz). Immunocomplexes were resolved by SDS-
PAGE and electroblotted to PVDF membrane. Immunoblotting 
was done with anti Cdc25A antibodies (1:500; Santa Cruz), or 
anti p38 (1:500, Cell Signalling) as the case may be and then with 
HRP conjugated Secondary antibody (1:5000; Bangalore Genei) and 
detected by Chemiluminiscence using 20X LumiGLO® Reagent and 
20X Peroxide (Cell Signalling Technology).
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